Insider · CIK 0001779479

Rolph Timothy

CIK 0001779479 Name as filed on the most recent filing

Filed as Rolph Timothy (31)

56 transaction lines · from 31 filings · filed 2022-09-15 to 2025-10-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

56 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-10-07 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 576,001, disposed Open Form 4 filing 0001193125-25-236152
2025-09-11 S, Open-market sale Akero Therapeutics, Inc.AKRO 23,790, disposed Open Form 4 filing 0000950170-25-114662
2025-09-08 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 552,137, disposed Open Form 4 filing 0001779479-25-000007
2025-08-05 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 616,299, disposed Open Form 4 filing 0000950170-25-104623
2025-07-07 S, Open-market sale Akero Therapeutics, Inc.AKRO 3 lines 638,661, disposed Open Form 4 filing 0000950170-25-094882
2025-06-18 S, Open-market sale Akero Therapeutics, Inc.AKRO 61,914, disposed Open Form 4 filing 0000950170-25-088638
2025-06-10 S, Open-market sale Akero Therapeutics, Inc.AKRO 127,323, disposed Open Form 4 filing 0000950170-25-085673
2025-06-06 S, Open-market sale Akero Therapeutics, Inc.AKRO 1,376,000, disposed Open Form 4 filing 0000950170-25-083878
2025-06-05 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 668,634, disposed Open Form 4 filing 0000950170-25-083878
2025-05-06 S, Open-market sale Akero Therapeutics, Inc.AKRO 3 lines 542,864, disposed Open Form 4 filing 0000950170-25-067381
2025-04-24 S, Open-market sale Akero Therapeutics, Inc.AKRO 256,438, disposed Open Form 4 filing 0000950170-25-059449
2025-04-07 S, Open-market sale Akero Therapeutics, Inc.AKRO 4 lines 224,262, disposed Open Form 4 filing 0000950170-25-052956
2025-03-12 S, Open-market sale Akero Therapeutics, Inc.AKRO 23,158, disposed Open Form 4 filing 0000950170-25-039731
2025-03-05 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 556,590, disposed Open Form 4 filing 0000950170-25-035709
2025-02-05 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 1,059,630, disposed Open Form 4 filing 0000950170-25-016493
2025-01-27 S, Open-market sale Akero Therapeutics, Inc.AKRO 3 lines 1,742,958, disposed Open Form 4 filing 0000950170-25-010707
2024-12-17 S, Open-market sale Akero Therapeutics, Inc.AKRO 118,172, disposed Open Form 4 filing 0000950170-24-138134
2024-12-10 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 148,934, disposed Open Form 4 filing 0000950170-24-136025
2024-09-10 S, Open-market sale Akero Therapeutics, Inc.AKRO 14,059, disposed Open Form 4 filing 0000950170-24-106458
2024-06-11 S, Open-market sale Akero Therapeutics, Inc.AKRO 53,886, disposed Open Form 4 filing 0000950170-24-073185
2024-03-13 S, Open-market sale Akero Therapeutics, Inc.AKRO 17,536, disposed Open Form 4 filing 0000950170-24-032261
2023-12-14 S, Open-market sale Akero Therapeutics, Inc.AKRO 10,671, disposed Open Form 4 filing 0000950170-23-071236
2023-09-13 S, Open-market sale Akero Therapeutics, Inc.AKRO 26,731, disposed Open Form 4 filing 0000950170-23-049764
2023-06-16 S, Open-market sale Akero Therapeutics, Inc.AKRO 3 lines 4,284,066, disposed Open Form 4 filing 0000950170-23-029227
2023-06-13 S, Open-market sale Akero Therapeutics, Inc.AKRO 28,076, disposed Open Form 4 filing 0000899243-23-015670
2022-12-29 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 1,037,119, disposed Open Form 4 filing 0000899243-22-039574
2022-12-28 S, Open-market sale Akero Therapeutics, Inc.AKRO 85,006, disposed Open Form 4 filing 0000899243-22-039574
2022-11-16 S, Open-market sale Akero Therapeutics, Inc.AKRO 2 lines 179,464, disposed Open Form 4 filing 0000899243-22-036055
2022-11-15 S, Open-market sale Akero Therapeutics, Inc.AKRO 141,343, disposed Open Form 4 filing 0000899243-22-036055
2022-10-26 S, Open-market sale Akero Therapeutics, Inc.AKRO 214,433, disposed Open Form 4 filing 0000899243-22-034372

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 56
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Rolph Timothy, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001779479

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.